Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Kendle International Inc. (KNDL)

No earlier versions found for this Subject.

Return to Kendle International Inc. (KNDL)

A clinical research organization (CRO). Recently made some
aquistions in Pacific Rim and Europe but this company remains
a small one relative to its peers, 1/10th the size of the leader Quintiles
Transnational. MRQ(Q3 97) revenues rose 247% and backlog up 196%.
Consolidation will come to this industry as we are now seeing
in the pharmaceuticals, making this a potential target?
Regardless KNDL looks like a good company on its own merits.
A profile can be found in IBD's New America 1/22/98 issue.

Home Page: kendle.com

Comments, Opinions, Discussion ?